ACS Nano · 2025 · 13 citations · 36 references
Life SciencesBioengineeringBiomedical EngineeringMolecular ImagingNanobiotechnologyNanomaterialsNanocarriers For TherapeuticsNanomedicinePhotothermal TherapyPulmonary EmbolismPulmonary Embolism ImagingTheranostic NanoparticlesActivatable Imaging ProbesCombination Photothermal TherapyNanomaterials For Photothermal TherapyNanoparticle Imaging AgentsNanoparticle Imaging ProbesNanoparticle-based ProbesNear-infrared Fluorescence ImagingTheranostic Nanomaterials
Pulmonary embolism (PE) is a life-threatening thrombotic condition, yet its precise diagnosis and effective treatment remain a major clinical challenge. In this study, we report the development of a microenvironment-activatable nanoplatform that enables hypoxia-triggered long-wavelength second near-infrared (NIR-II) fluorescence imaging for accurate thrombus visualization, combined with photothermal therapy (PTT) and controlled hydrogen sulfide (H 2 S) release for synergistic therapeutic intervention. We first synthesize an N -oxide-based molecular probe that undergoes hypoxia-induced structural transition, thereby activating both NIR-II fluorescence and photothermal properties. This probe, together with a thermosensitive H 2 S donor, is encapsulated into nanoparticles, which are further functionalized with bis-serotonin groups to achieve thrombus-specific targeting via the myeloperoxidase and hydrogen peroxide-mediated aggregation. In a PE mouse model, the nanoagent enables highly selective and sensitive visualization of thrombi via activatable NIR-II fluorescence imaging after intravenous injection, achieving a remarkable signal-to-noise ratio exceeding 120. The combined PTT and H 2 S therapy significantly enhance thrombolytic efficacy compared to conventional treatment (e.g., urokinase). Importantly, the nanoagent exhibits excellent biocompatibility in vivo, with minimal risk of hemorrhagic complications. This high-performance hypoxia-responsive platform offers a promising strategy for the precise diagnosis and effective treatment of PE and other cardiovascular diseases.
36
A small-molecule dye for NIR-II imaging
Alexander L. Antaris, Hao Chen, Kai Cheng et al. · Nature Materials · 2015 · 1.8K citations
Antithrombotic Therapy for VTE Disease
Scott M. Stevens, Scott C. Woller, Lisa Baumann Kreuziger et al. · CHEST Journal · 2021 · 955 citations
Lifetime-engineered NIR-II nanoparticles unlock multiplexed in vivo imaging
Yong Fan, Peiyuan Wang, Yiqing Lu et al. · Nature Nanotechnology · 2018 · 790 citations